Premium
Health related quality of life in patients with diabetic retinopathy
Author(s) -
TADROS C,
KONTODIMOPOULOS N,
FERETIS E,
KABANAROU SA,
PETO T
Publication year - 2011
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.2213.x
Subject(s) - medicine , diabetic retinopathy , diabetes mellitus , quality of life (healthcare) , population , maculopathy , retinopathy , mean value , ophthalmology , endocrinology , statistics , nursing , environmental health , mathematics
Purpose To assess Health‐Related Quality of Life (HRQoL) among Greek patients with Diabetic Retinopathy (DR) and Maculopathy(DMac) and to compare the results with data from existing studies. Methods Patients were recruited from the Diabetic Eye Clinic of the Hellenic Red Cross Hospital while attending their scheduled appointment. The study comprises of 85 patients with DR/DMac. HRQoL was measured using three different types of measurement, the NEI VFQ‐25, the SF‐12 and the EQ‐15D independently of their treatment. Results The response rate was 86.73%. There were 51 males, the average age was 57.7±16.4 years and the average duration of diabetes was 10.9±6.6 years.Patients with proliferative DR and existing DMac scored lower on all VFQ‐25 subscales compared to patients with non‐proliferative DR and those without DMac, respectively, especially in the dimensions "General Health"(34.2±24.9 versus 74.3±15.7 and 25.1±18.7 versus 69.8±19.2) and "Role Difficulties"(33.7±28.3 versus 87.7±25.2 and 23.6±23.1 versus 79.9±26.7). In the SF‐12 questionnaire the mean value in the Physical Component Scale (CS) was 45.6±11.3 and in the Mental CS was 45.2±16.8 while values in general Greek population are 49.4 and 48.9,respectively. In the EQ‐15D the mean value was significantly lower,0.761,while published values in Greek diabetic patients without DR are 0.813. Conclusion This study confirms that Greek patients with DR and DMac report poorer HRQoL than the general population. Therefore, the prvention and management of DR and DMac is essential to improve quality of life for these patients.